<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03161847</url>
  </required_header>
  <id_info>
    <org_study_id>16-326</org_study_id>
    <nct_id>NCT03161847</nct_id>
  </id_info>
  <brief_title>Natural History Study of Oculopharyngeal Muscular Dystrophy</brief_title>
  <acronym>NH-OPMD</acronym>
  <official_title>Natural History Study of Oculopharyngeal Muscular Dystrophy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of New Mexico</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Florida</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of New Mexico</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to test a set of clinical outcome measures longitudinally in a
      cohort of OPMD patients to identify ones that show quantifiable change over time as the
      disease progresses. The investigators' goal is to delineate the natural history of OPMD.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OPMD patients will undergo a screening evaluation and testing to confirm the participants
      carry the OPMD mutation. Subjects fulfilling the inclusion/exclusion criteria will be
      enrolled and followed prospectively at regular intervals to determine the natural history of
      this disease. Measures of muscle function and swallowing will be made at baseline and at
      follow-up visits to measure natural clinical progression.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 2017</start_date>
  <completion_date type="Anticipated">December 2024</completion_date>
  <primary_completion_date type="Anticipated">December 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Muscle Strength over time</measure>
    <time_frame>Baseline and every 9 months for 3 years</time_frame>
    <description>Change in Manual muscle testing over time</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Dysphagia severity over time</measure>
    <time_frame>Baseline and every 9 months for 3 years</time_frame>
    <description>Videofluoroscopic Swallow Studies</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Oculopharyngeal Muscular Dystrophy</condition>
  <arm_group>
    <arm_group_label>OPMD Subjects</arm_group_label>
    <description>The study cohort consists of individuals with genetically confirmed OPMD who will be followed longitudinally using periodic standardized assessments of clinical status in an observational, non-interventional study.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Non-interventional study</intervention_name>
    <description>Non-interventional study</description>
    <arm_group_label>OPMD Subjects</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Genetically Confirmed Oculopharyngeal Muscular Dystrophy
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  OPMD by genetic criteria

          -  â‰¥ 18 years old

          -  English-speaking

        Exclusion Criteria:

          -  Another medical condition that precludes safe completion of study tasks (such as
             severe cardiac or respiratory disease)

          -  Another medical condition that causes symptoms similar to OPMD (i.e., ptosis,
             dysphagia [trouble swallowing] or limb weakness).

          -  History of head or neck cancer, or history of radiation to the head or neck

          -  A videofluoroscopic swallow study within the 12 months prior to study enrollment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sarah Youssof, MD, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of New Mexico School of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sarah Youssof, MD, MS</last_name>
    <phone>505-272-6354</phone>
    <email>syoussof@salud.unm.edu</email>
  </overall_contact>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 16, 2017</study_first_submitted>
  <study_first_submitted_qc>May 18, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 22, 2017</study_first_posted>
  <last_update_submitted>May 18, 2017</last_update_submitted>
  <last_update_submitted_qc>May 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>OPMD</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muscular Dystrophies</mesh_term>
    <mesh_term>Muscular Dystrophy, Oculopharyngeal</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

